Recent Blog Posts

View Post: hi-tech pharmacal receives final approval for dorzolamide and ...
27 Jul 2009 by meansserve  
hi-tech pharmacal co., inc. (nasdaq: hitk) announced that the us provisions and drug administration (fda) granted final approval to the company's brief new drug application (anda) for dorzolamide and timolol ophthalmic decipherment, ...
View Blog: meansserve - http://uk.onbox.tv/meansserve/

---

View Post: Twenty-four Hour Ocular Perfusion Pressure Fluctuation and Risk of ...
2 Nov 2009 by Sung, KR, Lee, S., Park, SB, Choi, J.,...  
Approximately 20% of the patients with NTG in the present study were prescribed topical dorzolamide in a fixed combination with timolol. Therefore, we cannot completely rule out the effects of this combination on ocular blood flow or MOPP. .... Arch Ophthalmol. 1995;113:216–221.[Abstract/Free Full Text]; Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology. 2000;107:1287–1293. ...
View Blog: Investigative Ophthalmology & Visual Science... - http://www.iovs.org/

---

View Post: Court Denies Hi-Tech Pharmacal's Motion Regarding Dorzolamide and ...
12 Dec 2008
Hi-Tech had challenged the FDA's ruling that the Company had forfeited an exclusive generic marketing period for the Company's Dorzolamide and Timolol ophthalmic solution ANDA. The product is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta blockers. Hi-Tech launched Dorzolamide and Timolol on October 28, 2008 and continues to market the product. ...
View Blog: BioSpace.com Featured News and Stories - http://www.biospace.com/

---

View Post: (HITK) Top Performer for Wed: Hi-Tech Pharmacal- Zacks #1 Rank Top ...
3 Oct 2009 by vitalstocks  
This gain was attributed to recent product launches, such as glaucoma treatments Dorzolamide and Timolol ophthalmic solution and Dorzolomide ophthalmic solution. Furthermore, its Health Care Products division, which markets the ...
View Blog: Stock Blog Hub - http://www.stockbloghub.com/

---

View Post: Pros and Cons with Cosopt
29 Sep 2009 by Robert  
Cosopt is used to treat certain types of glaucoma and other causes of high pressure inside the eye. Cosopt contains dorzolamide and timolol. Dorzolamide ophthalmic reduces the amount of fluid in the eye, which decreases pressure inside ...
View Blog: The Pharmacy Technician - http://www.thepharmacytechnician.com/

---

View Post: Hi-Tech Pharmacal receives approval for dorzolamide, timolol ...
31 Oct 2008
Hi-Tech's dorzolamide and timolol solution is the generic equivalent of Merck's Cosopt ophthalmic solution and is indicated for reducing elevated IOP in patients with ocular hypertension or open-angle glaucoma. ...
View Blog: OSNSuperSite.com RSS Daily Feed - http://www.osnsupersite.com/

---

View Post: timolol dorzolamide thyroid drops
8 Mar 2008 by Paul Johnson  
dorzolamide and timolol ophthalmic - drugs & vitamins - liquid extracts library . eye drops to treat glaucoma if all products have pre-existing breathing or certain bladder conditions. show secondary search results for dorzolamide and ...
View Blog: Timolol - http://gregorytimolol.blogspot.com/

---

View Post: Prasco to Distribute Generic Forms of Dorzolamide Hydrochloride ...
28 Oct 2008
Dorzolamide hydrochloride-timolol maleate and dorzolamide hydrochloride ophthalmic solutions are indicated for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ...
View Blog: Latest Medical News from Bio-Medicine.Org - http://www.bio-medicine.org/medicine-news-1/

---

View Post: Predictors for visual field progression and the effects of ...
3 Oct 2009 by admin  
Purpose: This study aims to identify progression factors in patients with primary open-angle glaucoma (POAG), including the effects of treatment with dorzolamide 2% or brinzolamide 1%, each added to timolol 0.5%. ...
View Blog: idoctor - http://idoctor.ro/

---

View Post: Investors.com - Drugmaker Focuses On Niches The Bigger Companies ...
29 Sep 2009
Sold by Hi-Tech under the generic names Dorzolamide and Dorzolamide with Timolol, the eyedrops treat glaucoma and ocular hypertension. They brought Hi-Tech $9.7 million in the quarter. That's pretty good for a small company with 2009 ... Ophthalmic drug and device maker Alcon (ACL) eyes big returns from a pair of deals it signed over the past two months. Both transactions are designed to boost Alcon's presence in the treatment of age-related macular degeneration, or AMD. ...
View Blog: Investor's Business Daily - Investing RSS - http://www.investors.com/NewsAndAnalysis/

---